ALOX5AP and ovarian carcinoma: We found that ALOX5AP was significant higher both in RNA-seq analysis, based on TCGA-OV samples and matched normal control samples from the GTEx project (fold change: 4.14, p = 5.03e-25; Figure 1A), and microarray analysis, based on meta-analysis of the ovarian cancer GEO data sets (fold change: 1.76, p = 4.44e-04; Figure 1B).